Monopar Therapeutics Balance Sheet (2016-2025) | MNPR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	25.72M	23.84M	22.34M	20.01M	17.82M	16.46M	13.92M	8.19M	5.73M	7.21M	5.52M	7.27M	7.81M	6.12M	6.02M	45.82M	39.71M	39.50M	127.68M	61.83M
Prepaid Assets (Quarter)	0.11M	0.10M	0.11M	0.22M	0.19M	0.19M	0.06M	0.05M	0.11M	0.11M	0.07M	0.07M	0.12M	0.06M	0.05M	0.08M	0.52M	0.50M	0.41M	0.06M
Current Assets (Quarter)	25.84M	24.39M	22.45M	20.52M	18.01M	16.65M	14.37M	13.17M	11.78M	10.30M	8.57M	7.33M	8.91M	7.18M	6.07M	60.29M	55.08M	53.75M	144.09M	140.46M
Non-Current Assets
Long-Term Investments (Quarter)								4.93M	5.95M	2.98M	2.98M		0.99M	1.00M		14.40M	14.84M	13.75M	16.00M	78.57M
Long-Term Deferred Tax (Quarter)								11.14M				13.27M
Other Non-Current Assets (Quarter)	0.07M	0.07M	0.07M
Non-Current Assets (Quarter)	0.07M	0.07M	0.07M		0.05M	0.08M	0.07M	0.06M	0.05M	0.04M	0.03M	0.01M					0.01M	0.12M	0.11M	0.25M
Assets (Quarter)	25.91M	24.46M	22.52M	20.52M	18.07M	16.74M	14.45M	13.23M	11.83M	10.34M	8.59M	7.35M	8.91M	7.18M	6.07M	60.29M	55.09M	53.87M	144.20M	140.72M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	0.81M	1.10M	1.24M	1.58M	1.07M	2.19M	1.91M	3.13M	2.89M	2.50M	1.98M	1.76M	1.44M	1.09M	1.12M	2.25M	1.49M	1.58M	2.57M	2.74M
Payables (Quarter)	0.81M	1.10M	1.24M	1.58M	1.07M	2.19M	1.91M	3.13M	2.89M	2.50M	1.98M	1.76M	1.44M	1.09M	1.12M	2.25M	1.49M	1.58M	2.57M	2.74M
Short term Debt (Quarter)
Total Current Liabilities (Quarter)	0.81M			1.58M	1.07M	2.19M	1.91M	3.13M	2.89M	2.50M	1.98M	1.76M				5.25M		1.58M	2.57M	2.74M
Non-Current Liabilities
Non-Current Debt (Quarter)
Operating Leases (Quarter)					0.03M	0.08M	0.02M	0.01M										0.08M	0.07M	0.15M
Total Non-Current Liabilities (Quarter)																5.25M	1.49M	1.66M	2.64M	2.89M
Total Liabilities (Quarter)	0.81M	1.10M	1.24M	1.58M	1.10M	2.22M	1.94M	3.14M	2.89M	2.50M	1.98M	1.76M	1.44M	1.09M	1.12M	5.25M	1.49M	1.66M	2.64M	2.89M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	25.10M	23.35M	21.28M	18.94M	16.97M	14.52M	12.51M	10.09M	8.94M	7.84M	6.61M	5.59M	7.48M	6.09M	4.95M	55.04M	53.59M	52.20M	141.56M	137.83M
Shareholder's Equity (Quarter)	25.10M	23.35M	21.28M	18.94M	16.97M	14.52M	12.51M	10.09M	8.94M	7.84M	6.61M	5.59M	7.48M	6.09M	4.95M	55.04M	53.59M	52.20M	141.56M	137.83M
Liabilities and Shareholders Equity (Quarter)	25.91M	24.46M	22.52M	20.52M	18.07M	16.74M	14.45M	13.23M	11.83M	10.34M	8.59M	7.35M	8.91M	7.18M	6.07M	60.29M	55.09M	53.87M	144.20M	140.72M
Retained Earnings (Quarter)	-0.01M	-36.15M	-38.61M	-41.29M	-43.75M	0.02M	0.04M	-51.80M	-54.24M	-56.44M	0.00M	-60.21M	-61.80M	-63.56M	-0.01M	0.04M	-78.40M	-80.90M	0.01M	-89.50M
Preferred Shares (Quarter)
Treasury Shares (Quarter)	0.15M	0.13M	0.12M	0.11M	0.48M	0.34M	0.31M	0.05M		0.53M	0.47M	0.08M	0.37M	0.35M	0.05M	0.04M	0.15M	0.13M	0.11M	0.18M
Shares Outstanding (Quarter)	12.57M	12.58M	12.59M	12.60M	12.62M	12.70M	12.86M	2.59M	2.64M	2.78M	2.84M	2.98M	3.50M	17.60M	3.53M	6.10M	6.12M	6.13M	6.66M	6.69M

Research Tools

Developers

Monopar Therapeutics Balance Sheet (2016-2025) | MNPR

Research Tools

Developers

Monopar Therapeutics Balance Sheet (2016-2025) | MNPR

Create an account

Sign In

Reset Password